Literature DB >> 19277764

Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.

Sander M van Schaik, V I H Kwa, A J van der Kooi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19277764     DOI: 10.1007/s00415-009-5082-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.

Authors:  Steven Vernino; Vanda A Lennon
Journal:  Muscle Nerve       Date:  2002-11       Impact factor: 3.217

2.  Sporadic rippling muscle disease unmasked by simvastatin.

Authors:  Steven K Baker; Mark A Tarnopolsky
Journal:  Muscle Nerve       Date:  2006-10       Impact factor: 3.217

3.  Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.

Authors:  W Müller-Felber; C F Ansevin; K Ricker; A Müller-Jenssen; M Töpfer; H H Goebel; D E Pongratz
Journal:  Neuromuscul Disord       Date:  1999-12       Impact factor: 4.296

4.  Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.

Authors:  S Vernino; R G Auger; A M Emslie-Smith; C M Harper; V A Lennon
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

Review 5.  Rippling muscle disease: a review.

Authors:  Torberg Torbergsen
Journal:  Muscle Nerve Suppl       Date:  2002

6.  Rippling muscles and myasthenia gravis with rippling muscles.

Authors:  C F Ansevin; D P Agamanolis
Journal:  Arch Neurol       Date:  1996-02

7.  Acquired rippling muscle disease with myasthenia gravis.

Authors:  Steven A Greenberg
Journal:  Muscle Nerve       Date:  2004-01       Impact factor: 3.217

  7 in total
  1 in total

1.  Rippling Muscle Disease with Irregular Toe Jerks and Anti-acetylcholine Receptor Antibodies: Remission after Extended Thymectomy.

Authors:  Nanaka Yamaguchi; Shunichi Matsuda; Jun Matsumoto; Yoshikazu Ugawa; Jun Shimizu; Tatsushi Toda; Masahiro Sonoo; Toshihiro Yoshizawa
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.